Why is Oxygenta Pharma falling/rising?

As of 23-Oct, Oxygenta Pharmaceutical Ltd is experiencing a decline in its stock price, currently at Rs 58.30, which represents a decrease of 3.06 (-4.99%). The stock has been underperforming significantly, having fallen consecutively for the last three days, resulting in a total drop of 11.6% during this period. It opened the day with a loss of 4.99% and reached an intraday low of Rs 58.30. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Investor participation has also decreased, with delivery volume falling by 6.47% compared to the 5-day average. Unfortunately, there is no information available regarding positive or negative factors that could influence the stock's recent movement.
In the broader market context, Oxygenta Pharma's short-term performance has been notably poor compared to the benchmark, as it has declined by 7.18% over the past week while the Sensex has increased by 1.30%. Over the last month, the stock has decreased by 15.42%, contrasting sharply with the Sensex's gain of 2.99%. Year-to-date, Oxygenta Pharma has seen a significant decline of 33.35%, while the benchmark has risen by 8.21%. This stark contrast highlights the stock's underperformance relative to the broader market, contributing to the negative sentiment surrounding Oxygenta Pharmaceutical Ltd.